Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative Evaluation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Giuliano AE, Kirgan DM, Guenther MJ, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220(3): 391–401, 1994
Giuliano AE, Dale PS, Turner RR, Morton DL, Evans Sheila W, Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3): 394–401, 1995
Haid A, Fritzsche H, Peschina W, Gruber-Mösenbacher U, Jasarevic S, Hillbrand E, Köberle-Wührer R, Müller G, Schmidle T, Breitfellner G: Die Sentinel-Node-Biopsy beim Mammakarzinom: ein minimal invasives Verfahren zum exakten Staging der Axilla. Wien Klin Wochenschr111/6: 219–225, 1999
Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368–373, 1999
Wührer-Köberle R, Haid A, Eiter H, Zimmermann G: Zur Morbidität der Axilladissektion beim Mammakarzinom. In: Waclawiczek HW, Menzel Ch, Hausmanninger H, Kogelnik HD, Wolf G (eds) Die interdisziplinäre kurative Behandlung des Mammakarzinoms. Was ist Standard, was ist Routine? Barth, Heidelberg Leipzig, 1998
Hack TF, Cohen L, Katz J, Robson LS, Goss P: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1): 143–149, 1999
Schrenk P, Riegler M, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88: 608–614, 2000
Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner R: Prospective observational study of sentinel lymphadenectomy without axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18: 2553–2559, 2000
Kissin MW, Querci della Rovere G, Easton D, Westbury G: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73: 580–584, 1986
Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT: Assessment of morbidity from complete axillary dissection. Br J Surg 66: 136–138, 1992
Liljegren G, Holmberg L: Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage 1. Results from a randomised trial. Uppsala-Örebro Breast Cancer Study Group. Eur J Cancer 33(2): 193–199, 1997
Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen PV: Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 72: 365–367, 1985
Senofsky GM, Moffat Jr FL, Davis K, Masri MM, Clark KC, Robinson DS, Sabates B, Ketcham AS: Total axillary lymphadenektomy in the management of breast cancer. Arch Surg 126: 1336–1342, 1991
Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152: 765–772, 1981
Turner RR, Ollila DW, Krasne DL, Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271–278, 1997
Haid A, Hergan K, Oser W, Zimmermann G: Wertigkeit der präoperativen Axillasonographie beim Mammakarzinom. Langenbecks Arch Chir Suppl II: 97–100, 1996
Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R: Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64(3): 275–286, 2000